high altitude pulmonary oedema (HAPO)
You have 3 open access pages left.
UK healthcare workers and students can get FREE subscriptions... click here.

 
   

Acute altitude sickness occurs when an individual who is accustomed to low altitudes rapidly climbs to high altitude. Altitude sickness is a potentially lethal complication of climbing to altitudes above 8,000 feet.

Three main syndromes of altitude illness may affect travellers: acute mountain sickness, high altitude cerebral oedema (HACO), and high altitude pulmonary oedema (HAPO)

  • risk of dying from altitude related illnesses is low, at least for tourists. For trekkers to Nepal the death rate from all causes was 0.014% and from altitude illness 0.0036%
  • soldiers posted to altitude had an altitude related death rate of 0.16%

Clinical features of mild altitude sickness are (1):

  • headache
  • loss of appetite
  • nausea
  • fatigue
  • dizziness
  • insomnia
  • extremity oedema
  • dyspnoea
  • palpitations

There is an increased mortality in patients with acute altitude sickness.

Definitions of altitude and associated physiological changes

Intermediate altitude (1500-2500 metres)

  • physiological changes detectable
  • arterial oxygen saturation >90%
  • altitude illness possible but rare

High altitude (2500-3500 metres)

  • altitude illness common with rapid ascent
  • very high altitude (3500-5800 metres)
  • altitude illness common
  • arterial oxygen saturation <90%
  • marked hypoxaemia during exercise

Extreme altitude (>5800 metres)

  • marked hypoxaemia at rest
  • progressive deterioration, despite maximal acclimatisation
  • permanent survival cannot be maintained

Treatment of altitude related illness is to stop further ascent and, if symptoms are severe or getting worse, to descend

  • oxygen, drugs, and other treatments for altitude illness should be viewed as adjuncts to aid descent

Reference:

Links: